CompanyGraph
At a glance
- Depends onDownstream position: depends on 8 industries, supplies 5
- ScaleMarket cap is $247.54M, lower than 95% of all stocks globally
- PositionPrice-to-book is 0.27×, lower than 95% of its Internet Content & Information peers (median 2.06×)
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
247.54MUSDvs all stocks (USD)
Trailing P/E
14.57xvs Internet Content & Information peers
Revenue (TTM)
1.02BUSDvs all stocks (USD)
Profit Margin
1.93%vs Internet Content & Information peers
Beta
1.61xvs all stocks
52-Week Change
-61.96%vs all stocks
Market Capitalization
247.54MUSDvs all stocks (USD)
Enterprise Value
502.85MUSDvs all stocks (USD)
Trailing P/E
14.57xvs Internet Content & Information peers
Forward P/E
6.56xvs Internet Content & Information peers
PEG Ratio
-0.0841xvs Internet Content & Information peers
Price to Sales (TTM)
0.2420xvs Internet Content & Information peers
Price to Book (MRQ)
0.2704xvs Internet Content & Information peers
Enterprise to Revenue
0.4920xvs Internet Content & Information peers
Enterprise to EBITDA
4.35xvs Internet Content & Information peers
Gross Margin
95.93%vs Internet Content & Information peers
Profit Margin
1.93%vs Internet Content & Information peers
Operating Margin
2.29%vs Internet Content & Information peers
Return on Assets (TTM)
2.32%vs Internet Content & Information peers
Return on Equity (TTM)
2.01%vs Internet Content & Information peers
Revenue (TTM)
1.02BUSDvs all stocks (USD)
Revenue per Share (TTM)
23.58USDUpdated Jul 18, 2026Quarterly Revenue Growth
-3.20%vs Internet Content & Information peers
Gross Profit (TTM)
978.90MUSDvs all stocks (USD)
EBITDA (TTM)
117.85MUSDvs all stocks (USD)
Net Income (TTM)
19.75MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-3.16%vs Internet Content & Information peers
Operating Cash Flow (TTM)
90.28MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
38.79MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Internet Content & Information peers
Revenue
1.03BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
47.44MUSDFY2025 · Dec 31, 2025Gross Profit
983.10MUSDFY2025 · Dec 31, 2025Operating Income
78.19MUSDvs all stocks (USD)
Pre-tax Income
62.53MUSDFY2025 · Dec 31, 2025Income Tax Expense
18.70MUSDFY2025 · Dec 31, 2025Net Income
43.83MUSDFY2025 · Dec 31, 2025EBIT
83.00MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
142.90MUSDFY2025 · Dec 31, 2025Research & Development
87.36MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
770.42MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
15.74MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
20.47MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
43.83MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
56.58MUSDFY2025 · Dec 31, 2025Free Cash Flow
56.44MUSDDerived from operating cash flow minus capital expenditure. This filing charges 47.12M of depreciation against 145K of capital expenditure, and its own free-cash-flow line reads 45.47M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
303.70MUSDFY2025 · Dec 31, 2025Income Tax Paid
7.55MUSDFY2025 · Dec 31, 2025Interest Paid
19.38MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
43.83MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
47.12MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
13.17MUSDFY2025 · Dec 31, 2025Stock-based Compensation
14.76MUSDFY2025 · Dec 31, 2025Other Non-cash Items
6.18MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-43.75MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-3.83MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-20.89MUSDFY2025 · Dec 31, 2025Capital Expenditures
145.00KUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Purchase of Investments
0.00USDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
145.00KUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-148.68MUSDFY2025 · Dec 31, 2025Other Financing Charges
-9.67MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-158.34MUSDFY2025 · Dec 31, 2025Shares Outstanding
40.42MSharesUpdated Jul 18, 2026Float Shares
28.56MSharesUpdated Jul 18, 2026Shares Short
5.00MSharesUpdated Jul 18, 2026Short Ratio
4.34daysvs all stocks
Short % of Shares Outstanding
12.69%vs all stocks
% Held by Insiders
11.35%vs all stocks
% Held by Institutions
91.46%vs all stocks
Total Cash (MRQ)
244.58MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
6.05USDUpdated Jul 18, 2026Total Debt (MRQ)
499.89MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.5465xvs Internet Content & Information peers
Current Ratio (MRQ)
1.50xvs Internet Content & Information peers
Book Value per Share (MRQ)
22.63USDUpdated Jul 18, 2026Total Assets
1.68BUSDvs all stocks (USD)
Total Current Assets
366.38MUSDFY2025 · Dec 31, 2025Total Liabilities
753.00MUSDFY2025 · Dec 31, 2025Total Non-current Assets
1.31BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
530.56MUSDFY2025 · Dec 31, 2025Total Current Liabilities
222.44MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
303.70MUSDFY2025 · Dec 31, 2025Accounts Receivable
33.05MUSDFY2025 · Dec 31, 2025Accounts Payable
34.03MUSDFY2025 · Dec 31, 2025Short-term Debt
13.46MUSDFY2025 · Dec 31, 2025Deferred Revenue
22.10MUSDFY2025 · Dec 31, 2025Other Current Liabilities
83.29MUSDFY2025 · Dec 31, 2025Long-term Debt
497.67MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
31.40MUSDFY2025 · Dec 31, 2025Common Stock (Book)
538.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-150.88MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
927.37MUSDvs all stocks (USD)
Treasury Stock
355.92MUSDFY2025 · Dec 31, 202552-Week Low
4.53USDUpdated Jul 18, 202652-Week High
19.42USDUpdated Jul 18, 202652-Week Change
-61.96%vs all stocks
Beta
1.61xvs all stocks
50-Day MA
5.65USDUpdated Jul 18, 2026200-Day MA
9.54USDUpdated Jul 18, 2026Avg 10-Day Volume
489.38KSharesUpdated Jul 18, 2026Avg 30-Day Volume
851.05KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
0.4200USDUpdated Jul 18, 2026Other Income / Expense
-10.94MUSDFY2025 · Dec 31, 20255 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Rising Operating Income With Falling Gross Profit and Shrinking Assets
Operating income has risen while gross profit and the asset base both shrank.
Reads
Diagnostic
Operating Income Up Despite Gross Profit Decline, Margins Elevated
Operating income keeps rising while gross profit falls, so the gain sits below that line.
Reads
Diagnostic
Rising Operating Income With Falling Gross Profit and Heavy Depreciation
Operating income rose four years while gross profit fell, on heavy depreciation.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.27×, lower than 95% of its Internet Content & Information peers (median 2.06×)Notable
Price-to-book: 0.27Industry median: 2.06Industry P5: 0.34Peers compared: 29.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.96Profit Margin: 0.02
Prioritizing buybacks over growth reinvestmentNotable
Buyback Intensity: 0.60Revenue Growth YoY: -0.03
Financial Health
Altman Z-Score 0.95: distress zoneCritical
Altman Z-Score: 0.95
Supply Chain
Downstream position: depends on 8 industries, supplies 5Notable
Outgoing: 5.00Incoming: 8.00
High connectivity hub: 13 industry connectionsNotable
Total Connections: 13.00
Scale
Market cap is $247.54M, lower than 95% of all stocks globallySignificant
Market cap (USD): 247,541,857Global P5: 269,387,740.27
Revenue is $1.02B, above the global median of $520.53MNotable
Revenue (USD): 1,022,771,968Global Median: 520,528,949.311
Levered free cash flow is $38.79M, above the global median of $16.24MNotable
Levered free cash flow (USD): 38,790,000Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Inkeverse Group Ltd.
Tier 1InterfacePlatform IntermediationAttentionFlow
Overstock.com Inc
Tier 1InterfacePlatform IntermediationFlowAttention
Pr Times Corp.
Tier 1InterfacePlatform IntermediationAttentionFlow
EaseMyTrip Planners Ltd.
Tier 1InterfacePlatform IntermediationFlowSenseMaking
KNT-CT Holdings Co., Ltd.
Tier 1InterfacePlatform IntermediationFlowAttention
Shutterstock Inc.
Tier 1InterfacePlatform IntermediationAttentionFlow
Sunfun Info Co., Ltd.
Tier 1InterfacePlatform IntermediationAttentionFlow
Getty Images Holdings, Inc.
Tier 1InterfacePlatform IntermediationAttentionFlow
Xi'an Qujiang Cultural Tourism Co., Ltd.
Tier 1InterfacePlatform IntermediationAttentionProduction
Everyday Network Co., Ltd.
Tier 1InterfacePlatform IntermediationAttentionSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Ginkgo Bioworks Holdings Inc.
3 interpretationsOperating Income Up Despite Gross Profit Decline, Margins ElevatedRising Operating Income With Falling Gross Profit and Shrinking AssetsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Anbio Biotechnology Limited
2 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Neuromeka Co., Ltd.
2 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated